• Ketamine for Sickle Cell Disease
    Aug 28 2024

    InpharmD's EBM podcast focuses on commonly asked drug information questions and the associated literature. This episode focuses on the use of ketamine for Sickle Cell Disease.

    Show More Show Less
    13 mins
  • Tirzepatide for Sleep Apnea
    Jul 26 2024

    InpharmD's EBM podcast focuses on commonly asked drug information (DI) questions and the associated literature. Everyday, our queue gets tons of questions asked by health care providers all around the country. For this episode, we assess tirzepatide for obstructive sleep apnea and analyze the SURMOUNT-OSA clinical trials.

    Show More Show Less
    11 mins
  • Excoriation Disorder
    May 28 2024

    InpharmD's EBM podcast focuses on commonly asked drug information (DI) questions and the associated literature. Everyday, our queue gets tons of questions asked by health care providers all around the country. For this episode, we assess treatment options for excoriation disorder.

    Show More Show Less
    11 mins
  • Phenytoin for Tacrolimus Toxicity
    Apr 25 2024

    InpharmD's EBM podcast focuses on commonly asked DI questions. Every day, our queue gets tons of new questions asked from providers all around the country. Today's podcast focuses on the use of phenytoin to treat tacrolimus toxicity.

    Show More Show Less
    14 mins
  • Atypical Antipsychotics and QT–prolongation
    Feb 27 2024

    InpharmD's EBM podcast focuses on commonly asked drug information questions. Every day, our queue gets tons of new questions asked from providers all around the country. One question that's been garnering a lot of views from our users right now is which atypical antipsychotics are associated with the lowest and highest risk of QT prolongation.

    Show More Show Less
    11 mins
  • Apixaban in Peripheral Artery Disease
    Nov 30 2023

    Join InpharmD as we discuss the role of apixaban in peripheral artery disease.

    Show More Show Less
    11 mins
  • Safety and Efficacy of RSV Vaccines
    Sep 27 2023

    Join InpharmD as we discuss the safety and efficacy of two FDA-approved RSV vaccines, Arexvy and Abrysvo.

    Show More Show Less
    10 mins
  • Safety and Efficacy of Rezafungin
    Jul 20 2023

    Join us as we discuss the data surrounding newly approved antifungal agent, rezafungin. Interested in learning more? Join our CE on rezafungin on July 27th at 12:00 PM EST - open to all pharmacists!

    Show More Show Less
    10 mins